Investigating the Protective Effects of Interleukin 22 on Intestinal Epithelium: Potential Graft-versus-Host Disease Treatment
ISEF · 2015 Third Award
Overview
Gastrointestinal graft-versus-host disease (GVHD) is a severe complication of allogeneic hematopoietic stem cell transplantation in which donor T cells attack host tissues. Immunosuppressants are utilized as a primary therapy for GVHD, however their side effects often inhibit patient recovery. As a result, alternative GVHD treatments are critical. While interleukin 22 (IL-22) deficiency has been linked to worsened GVHD in a murine model, the protective mechanism of IL-22 in the intestine remain unclear. Thus, we aimed to elucidate the effects of IL-22 on intestinal epithelium to determine if IL-22 treatment can improve tissue recovery in GVHD. Three-dimensional murine organoids that mimic intestinal crypt structure in vivo were cultured and treated with recombinant murine IL-22. Subsequently, a novel quantitation technique was used to assess organoid growth. We found that IL-22 increased small intestinal (p<0.0001) and large intestinal (p<0.05) organoid size, indicating increased proliferation and potential protection from GVHD. Additionally, new crypt formation in organoids (p<0.05) and percentages of intestinal stem cells (ISCs; p<0.05) were increased by IL-22. This increased growth was associated with activation of the IL-22 receptor pathway preferentially in intestinal stem cells (ISCs), suggesting direct effects of IL-22 on ISCs. These findings are the first to indicate that IL-22 promotes intestinal regeneration by functioning as an ISC growth factor. Treatment of murine organoids with recombinant human IL-22 also resulted in increased proliferation of intestinal cells (p<0.05), suggesting human IL-22 may be a promising candidate for tissue regeneration therapies for patients with intestinal pathology.
Awards (1)
- Third Award of $1,000 $1,000
Competition history
- ISEF 2015
Resources
Related projects
ISEF · 2021
The Effect of IL-22 Stimulation on Paneth Cell Granule Morphology and Epithelial Cell Proliferation
ISEF · 2015
GVHD Prophylaxis: A Novel Approach for Using the HCMV Glycoproteins to Downregulate MHC Class I and Class II Antigen Presentation Pathways
ISEF · 2024
Investigating the Efficacy and Mechanisms of Mesenchymal Stem Cell Therapy in Celiac Disease: Year 2
ISEF · 2017
Statistical Analysis of Graft vs. Host Disease and Immune Reconstitution in Humanized Mice
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair